IP Library › Assignment 050280/0286
Patent Assignment
Reel/Frame 050280/0286

Assignment of Assignor's Interest

Recorded: 2019-09-05 Pages: 5
Assignor
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Property (1)
Treatment of Cancer Using Humanized Anti-Egfrviii Chimeric Antigen Receptor
Application: 16/382,402 →
Publication: US 2019/0330356
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 5, 2019
From: JOHNSON, LAURA ALEXANDRA; JUNE, CARL H.; MAUS, MARCELA; SCHOLLER, JOHN
To: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Reel/Frame 050280/0191 →
Assignment of Assignor's Interest Sep 5, 2019
From: BROGDON, JENNIFER
To: NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.
Reel/Frame 050280/0050 →
Assignment of Assignor's Interest Sep 5, 2019
From: OKADA, HIDEHO
To: UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
Reel/Frame 050280/0098 →
Assignment of Assignor's Interest Dec 28, 2022
From: LOEW, ANDREAS
To: NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.
Reel/Frame 062221/0720 →